Targeting WNK1 Releases Differentiation Block in Acute Myeloid Leukemia

Abstract excerpt

Impaired differentiation is a hallmark of Acute Myeloid Leukemia (AML). Current differentiation therapies benefit only a small subset of AML patients, leaving a substantial gap in care for other subtypes. Identifying novel molecular drivers of maturation arrest is critical to expand differentiation induction to a broader range of AML patients. This study addresses this unmet clinical need, by identifying With-no-L...

Topics

Open a Topic to create a Post that cites this publication.

• Epigenetics and DNA Methylation
• Acute Myeloid Leukemia Research
• Histone Deacetylase Inhibitors Research
• Leukemia, Myeloid, Acute
• Mutation
• Nuclear Structure and Function
• Protein Degradation and Inhibitors
• Ubiquitin and proteasome pathways

Identifiers and source

Literature Corpus work

a421a12d-315a-569b-ad33-2a03ff569364

DOI

10.64898/2026.04.22.720037